Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands

Groof, E. Joline de; Rossen, Noortje; Rhijn, Bram D. van; Karregat, Evert P.M.; Boonstra, Kirsten; Hageman, Ishtu; Evertsz, Floor Bennebroek; Kingma, Paul J.; Naber, A.H.J.; Brande, Jan H. M. van den; Mallant-Hent, Rosalie C.; Mundt, Marco W.; D’Haens, Geert R.; Ponsioen, Cyriel Y.

doi:10.1097/meg.0000000000000660

Cited by 53 publications

(37 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Europe, PSC was present in 2-4% of all UC patients in comparison to 0-1.7% in Asia. 17,[44][45][46] (Fig. 4).…”

Section: Presence Of Extra-intestinal Manifestations Ibd Is Associatmentioning

confidence: 95%

“…Primary sclerosing cholangitis (PSC) also appears less prevalent in the East. In Europe, PSC was present in 2–4% of all UC patients in comparison to 0–1.7% in Asia . (Fig.…”

Section: Clinical Features Of Ibdmentioning

confidence: 96%

“…In western populations, joint manifestations (both peripheral and axial arthropathy) were the most common EIMs and affected 17–30% of IBD patients . Similarly, peripheral arthritis was the most common EIM in Taiwan and was present in 6.1% of IBD patients .…”

Section: Clinical Features Of Ibdmentioning

confidence: 99%

“…45 In western populations, joint manifestations (both peripheral and axial arthropathy) were the most common EIMs and affected 17- 30% of IBD patients. 17,46 Similarly, peripheral arthritis was the most common EIM in Taiwan and was present in 6.1% of IBD patients. 45 Skin (5-15% vs. 0.3-1.8%) and ocular manifestations (3-6% to 0.1-0.3%) were more frequently reported in the West than in the East.…”

Section: Presence Of Extra-intestinal Manifestations Ibd Is Associatmentioning

confidence: 99%

“…Summary of the latest reported incidence of inflammatory bowel diseases (IBD) according to population‐based studies from 2010 to 2019 …”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

The epidemiology of inflammatory bowel disease: East meets west

Mak

Zhao

et al. 2019

J of Gastro and Hepatol

422

291

View full text Add to dashboard Cite

The incidence of inflammatory bowel diseases (IBD) in East has risen over the past decade to become a global disease. The increasing number of studies on the incidence and course of IBD in East has enabled us to explore East versus West differences in the epidemiology of IBD which could enhance our understanding of the heterogeneity of the disease and eventually assist in the discovery of novel therapeutic targets and design of preventive strategies. Comparison of population‐based data in East and West reveals that the incidence of IBD has risen rapidly in East while plateauing in West. Furthermore, the clinical presentation and course of IBD differs between East and West with more patients in East presenting with complicated disease. Considering the scarcity of population‐based data from East and the lack of studies with long durations of follow‐up, it remains to be clarified whether these differences reflect true differences in disease presentation. The effects of genetic and environmental risk factors contributing to IBD also differ between Eastern and Western populations. Considering the differential effects of genetic and environmental risk factors in East and West, future studies should seek to discover novel genetic and environmental risk factors which might specifically apply to eastern populations. In this narrative review, we compare the epidemiology of IBD between eastern and western countries by summarizing evidence from population‐based cohort studies in the last ten years. Furthermore, we look at differences in genetic susceptibility and environmental triggers of IBD between East and West.

show abstract

“…In Europe, PSC was present in 2-4% of all UC patients in comparison to 0-1.7% in Asia. 17,[44][45][46] (Fig. 4).…”

Section: Presence Of Extra-intestinal Manifestations Ibd Is Associatmentioning

confidence: 95%

“…Primary sclerosing cholangitis (PSC) also appears less prevalent in the East. In Europe, PSC was present in 2–4% of all UC patients in comparison to 0–1.7% in Asia . (Fig.…”

Section: Clinical Features Of Ibdmentioning

confidence: 96%

Section: Clinical Features Of Ibdmentioning

confidence: 99%